Elisabeth A Kastelijn1, Sherif Y El Sharouni2, Frederik N Hofman3, Bart P Van Putte3, Evelyn M Monninkhof4, Marco Van Vulpen2, Franz M N H Schramel5. 1. Department of Pulmonology, St. Antonius Hospital, Nieuwegein, the Netherlands. 2. Department of Radiotherapy, University Medical Centre Utrecht, Utrecht, the Netherlands. 3. Department of Cardiothoracic Surgery, St. Antonius Hospital, Nieuwegein, the Netherlands. 4. Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, the Netherlands. 5. Department of Pulmonology, St. Antonius Hospital, Nieuwegein, the Netherlands f.schramel@antoniusziekenhuis.nl.
Abstract
BACKGROUND: Surgical resection is the treatment of first choice for patients with stage I-II non-small cell lung cancer (NSCLC). However, stereotactic body radiotherapy (SBRT) has been shown to be a good alternative treatment. PATIENTS AND METHODS: Overall survival (OS), progression-free survival (PFS) and recurrence rates were compared between patients with stage I-II NSCLC treated with SBRT (n=53) and those treated with surgical resection (n=175). The propensity score method was used to correct for confounding by indication. RESULTS: Before correction, the OS and PFS rates at 1 and 3 years were significantly different between SBRT and surgery, in favor of surgery. After correction, the OS and PFS after SBRT were not significantly different compared to surgery. The recurrence rates for the two treatments were also similar both before and after correction. CONCLUSION: This retrospective study showed that clinical outcomes after SBRT are equal to those after surgery in patients with stage I-II NSCLC. Copyright
BACKGROUND: Surgical resection is the treatment of first choice for patients with stage I-II non-small cell lung cancer (NSCLC). However, stereotactic body radiotherapy (SBRT) has been shown to be a good alternative treatment. PATIENTS AND METHODS: Overall survival (OS), progression-free survival (PFS) and recurrence rates were compared between patients with stage I-II NSCLC treated with SBRT (n=53) and those treated with surgical resection (n=175). The propensity score method was used to correct for confounding by indication. RESULTS: Before correction, the OS and PFS rates at 1 and 3 years were significantly different between SBRT and surgery, in favor of surgery. After correction, the OS and PFS after SBRT were not significantly different compared to surgery. The recurrence rates for the two treatments were also similar both before and after correction. CONCLUSION: This retrospective study showed that clinical outcomes after SBRT are equal to those after surgery in patients with stage I-II NSCLC. Copyright
Authors: Henry S Park; Frank C Detterbeck; David C Madoff; Brett C Bade; Ulas Kumbasar; Vincent J Mase; Andrew X Li; Justin D Blasberg; Gavitt A Woodard; Whitney S Brandt; Roy H Decker Journal: J Thorac Dis Date: 2022-06 Impact factor: 3.005
Authors: Christopher Cao; Daniel Wang; Caroline Chung; David Tian; Andreas Rimner; James Huang; David R Jones Journal: J Thorac Cardiovasc Surg Date: 2018-09-15 Impact factor: 5.209
Authors: Karlijn J G Schulkes; Cindy Nguyen; Frederiek van den Bos; Leontine J R van Elden; Marije E Hamaker Journal: Lung Date: 2016-09-20 Impact factor: 2.584
Authors: Karlijn J G Schulkes; Cindy Nguyen; Frederiek van den Bos; Marije E Hamaker; Leontine J R van Elden Journal: Lung Date: 2016-06-10 Impact factor: 2.584